• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

土耳其一家新冠肺炎医院感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的医护人员特征:同源疫苗接种与异源疫苗接种。

Characteristics of health care workers with SARS-CoV-2 at a COVID-19 hospital in Türkiye: Homologous versus heterologous vaccination.

作者信息

Alıravcı Isıl Deniz, Ertekin Yusuf Haydar, Can Gamze, Alkan Sevil

机构信息

Işıl Deniz Alıravcı, MD Assistant Professor, Department of Infectious Diseases and Clinical Microbiology, Canakkale Onsekiz Mart University, Canakkale, Türkiye.

Yusuf Haydar Ertekin, MD Associate Professor, Department of Family Medicine, Canakkale Onsekiz Mart University, Canakkale, Türkiye.

出版信息

Pak J Med Sci. 2024 Sep;40(8):1702-1708. doi: 10.12669/pjms.40.8.8455.

DOI:10.12669/pjms.40.8.8455
PMID:39281253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11395381/
Abstract

OBJECTIVE

Given the limited studies on types of vaccination and infection rates among health care workers (HCWs) in Türkiye, we analyzed the demographic, clinical, and vaccination characteristics as well as the attitudes of HCWs who have been infected with COVID-19.

METHODS

We retrospectively analyzed demographic and clinical data on breakthrough COVID-19 infections in HCWs from hospital surveillance data collected between April 5, 2020, and November 1, 2022. The comparison was based on four subgroups that consisted of unvaccinated, one-shot-vaccinated, homologous vaccinated, and heterologous vaccinated individuals. Participants who received various combinations of Sinovac/CoronaVac and/or BioNTech/Pfizer vaccines were compared for detection of COVID-19.

RESULTS

During a 33-month period of 744 HCWs who contracted COVID-19, women (65.3%) and nurses (28.9%) were the most affected, followed by doctors (25.8%). Of the infected HCWs, only 1.3% required hospitalization, 0.3% required ICU support, and 98.4% were outpatients. By vaccination status, 143 of the HCWs (19.2%) were unvaccinated, 292 (39.2%) were homologously vaccinated, 294 (39.5%) were heterologously vaccinated, 15 (2%) received a single shot, 206 (27.7%) received two shots, and 165 (22.2%) received three shots. All HCWs contracted COVID-19 at a mean of 134-days (range:1-539) after vaccination. While the proportions of homologously and heterologously vaccinated HCWs were similar, the time elapsed from vaccination to contracting COVID-19 varied (mean 143.4±106.7 vs.126.4±82.43 days).

CONCLUSIONS

Among both outpatients and inpatients with COVID-19, women HCWs outnumbered men HCWs. HCWs who received homologous vaccination contracted COVID-19 later than those who received heterologous vaccination.

摘要

目的

鉴于土耳其针对医护人员疫苗接种类型和感染率的研究有限,我们分析了感染新型冠状病毒肺炎(COVID-19)的医护人员的人口统计学、临床和疫苗接种特征以及他们的态度。

方法

我们回顾性分析了2020年4月5日至2022年11月1日期间从医院监测数据中获取的医护人员COVID-19突破性感染的人口统计学和临床数据。比较基于四个亚组,分别为未接种疫苗、接种一剂疫苗、同源接种和异源接种的个体。对接受了科兴/克尔来福和/或辉瑞/BioNTech疫苗不同组合的参与者进行COVID-19检测比较。

结果

在33个月期间,744名感染COVID-19的医护人员中,女性(65.3%)和护士(28.9%)受影响最大,其次是医生(25.8%)。在感染的医护人员中,只有1.3%需要住院治疗,0.3%需要重症监护病房(ICU)支持,98.4%为门诊患者。按疫苗接种状况划分,143名医护人员(19.2%)未接种疫苗,292名(39.2%)为同源接种,294名(39.5%)为异源接种,15名(2%)接种了一剂,206名(27.7%)接种了两剂,165名(22.2%)接种了三剂。所有医护人员在接种疫苗后平均134天(范围:1 - 539天)感染COVID-19。虽然同源接种和异源接种的医护人员比例相似,但从接种疫苗到感染COVID-19的时间有所不同(平均143.4±106.7天对126.4±82.43天)。

结论

在COVID-19门诊和住院患者中,女性医护人员数量多于男性医护人员。接受同源接种的医护人员比接受异源接种的医护人员感染COVID-19的时间更晚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a14/11395381/a8dcd92c0a0f/PJMS-40-1702-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a14/11395381/a8dcd92c0a0f/PJMS-40-1702-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a14/11395381/a8dcd92c0a0f/PJMS-40-1702-g001.jpg

相似文献

1
Characteristics of health care workers with SARS-CoV-2 at a COVID-19 hospital in Türkiye: Homologous versus heterologous vaccination.土耳其一家新冠肺炎医院感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的医护人员特征:同源疫苗接种与异源疫苗接种。
Pak J Med Sci. 2024 Sep;40(8):1702-1708. doi: 10.12669/pjms.40.8.8455.
2
[Efficacy of Homologous and Heterologous Vaccine Applications on SARS-CoV-2 Omicron Variant: Cohort of Manisa Celal Bayar University Healthcare Workers].[同源和异源疫苗接种对严重急性呼吸综合征冠状病毒2奥密克戎变异株的效果:马尼萨杰拉尔·拜亚尔大学医护人员队列研究]
Mikrobiyol Bul. 2023 Apr;57(2):238-251. doi: 10.5578/mb.20239918.
3
Risks of catching COVID-19 according to vaccination status of healthcare workers during the SARS-CoV-2 Delta variant dominant period and their clinical characteristics.根据 SARS-CoV-2 德尔塔变异株流行期间医护人员的疫苗接种状态,以及他们的临床特征,评估感染 COVID-19 的风险。
J Med Virol. 2022 Aug;94(8):3706-3713. doi: 10.1002/jmv.27778. Epub 2022 Apr 23.
4
Vaccination Hesitancy among Health-Care-Workers in Academic Hospitals Is Associated with a 12-Fold Increase in the Risk of COVID-19 Infection: A Nine-Month Greek Cohort Study.学术医院医护人员的疫苗犹豫与 COVID-19 感染风险增加 12 倍相关:一项为期九个月的希腊队列研究。
Viruses. 2021 Dec 24;14(1):26. doi: 10.3390/v14010026.
5
[The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].科兴新冠疫苗第二针可能导致曾感染新冠病毒者抗体水平下降
Mikrobiyol Bul. 2022 Jan;56(1):139-142. doi: 10.5578/mb.20229913.
6
Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy).的里雅斯特教学医院(意大利东北部)医护人员中新冠病毒疫苗突破性感染的风险及相关因素
Viruses. 2022 Feb 7;14(2):336. doi: 10.3390/v14020336.
7
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.同源和异源加强针对于灭活 SARS-CoV-2 疫苗的有效性:一项大规模前瞻性队列研究。
Lancet Glob Health. 2022 Jun;10(6):e798-e806. doi: 10.1016/S2214-109X(22)00112-7. Epub 2022 Apr 23.
8
Effectiveness of CoronaVac in preventing COVID-19 in healthcare workers.科兴新冠疫苗在医护人员中的 COVID-19 预防效果。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2020017. doi: 10.1080/21645515.2021.2020017. Epub 2022 Feb 16.
9
Heterologous and homologous COVID-19 mRNA vaccination schemes for induction of basic immunity show similar immunogenicity regarding long-term spike-specific cellular immunity in healthcare workers.不同和同源的 COVID-19 mRNA 疫苗接种方案在诱导医护人员的长期刺突特异性细胞免疫方面显示出相似的免疫原性。
Vaccine. 2024 Aug 30;42(21):126132. doi: 10.1016/j.vaccine.2024.07.033. Epub 2024 Jul 20.
10
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.BNT162b2 疫苗接种与医护人员中出现有症状和无症状 SARS-CoV-2 感染的相关性。
JAMA. 2021 Jun 22;325(24):2457-2465. doi: 10.1001/jama.2021.7152.

本文引用的文献

1
Heterologous Vector-mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector-Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines.在德国医护人员中,基于异源载体 - mRNA的新冠病毒疫苗接种策略在体液新冠病毒反应方面似乎优于基于同源载体的疫苗接种方案,这表明mRNA疫苗具有很高的增强效果。
Vaccines (Basel). 2023 Mar 19;11(3):701. doi: 10.3390/vaccines11030701.
2
Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection.腺病毒载体 ChAdOx1 疫苗和 BNT162b2 疫苗对 SARS-CoV-2 感染的保护持续时间。
Clin Drug Investig. 2022 Oct;42(10):799-806. doi: 10.1007/s40261-022-01195-x. Epub 2022 Aug 30.
3
Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis.
异源和同源 COVID-19 疫苗方案的有效性:基于网络荟萃分析的实时系统评价。
BMJ. 2022 May 31;377:e069989. doi: 10.1136/bmj-2022-069989.
4
Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans.同源或异源新冠病毒加强针在退伍军人中的有效性。
N Engl J Med. 2022 Apr 7;386(14):1375-1377. doi: 10.1056/NEJMc2200415. Epub 2022 Feb 9.
5
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina.北卡罗来纳州 9 个月期间的新冠疫苗有效性。
N Engl J Med. 2022 Mar 10;386(10):933-941. doi: 10.1056/NEJMoa2117128. Epub 2022 Jan 12.
6
Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups.辉瑞-生物科技和牛津阿斯利康 COVID-19 疫苗在临床风险人群中的有效性和免疫反应。
J Infect. 2022 May;84(5):675-683. doi: 10.1016/j.jinf.2021.12.044. Epub 2022 Jan 3.
7
Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic.关于新冠病毒疫苗及严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变种在疫情中作用的综合文献综述。
Ther Adv Vaccines Immunother. 2021 Nov 24;9:25151355211059791. doi: 10.1177/25151355211059791. eCollection 2021.
8
Breakthrough Infection With Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Delhi: A Single-Institution Study.德里医护人员中严重急性呼吸综合征冠状病毒2突破性感染:一项单机构研究
Cureus. 2021 Oct 27;13(10):e19070. doi: 10.7759/cureus.19070. eCollection 2021 Oct.
9
Postvaccination SARS-CoV-2 infection among healthcare workers: A systematic review and meta-analysis.接种疫苗后医护人员中 SARS-CoV-2 感染:系统评价和荟萃分析。
J Med Virol. 2022 Apr;94(4):1428-1441. doi: 10.1002/jmv.27457. Epub 2021 Nov 24.
10
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.比较 COVID-19 疫苗在针对 SARS-CoV-2 及其关注变异株的特性、疗效和有效性方面的差异:一项叙述性综述。
Clin Microbiol Infect. 2022 Feb;28(2):202-221. doi: 10.1016/j.cmi.2021.10.005. Epub 2021 Oct 27.